世界の多発性内分泌腺腫症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multiple Endocrine Neoplasia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3952
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、多発性内分泌腺腫症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・多発性内分泌腺腫症治療の市場動向
・企業の競争状況、市場シェア
・多発性内分泌腺腫症治療の種類別市場規模（薬物治療、外科治療）
・多発性内分泌腺腫症治療の用途別市場規模（病院、クリニック、その他）
・多発性内分泌腺腫症治療の北米市場規模2016-2027（アメリカ、カナダ）
・多発性内分泌腺腫症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・多発性内分泌腺腫症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多発性内分泌腺腫症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・多発性内分泌腺腫症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（West Coast Pharmaceuticals、Solvay、Unicure India、Sun Pharmaceuticals Industries、Macleods Pharmaceuticals）
・結論

Multiple Endocrine Neoplasia is a disease caused by genetic mutation. Multiple Endocrine Neoplasia is inherited from one generation to another generation. The symptoms of the multiple endocrine neoplasia depends on the type of gland which is affected by the disease. The multiple endocrine neoplasia has been classified according to the gland which is affected by the disease.

Market Analysis and Insights: Global Multiple Endocrine Neoplasia Treatment Market
The global Multiple Endocrine Neoplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiple Endocrine Neoplasia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiple Endocrine Neoplasia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiple Endocrine Neoplasia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiple Endocrine Neoplasia Treatment market.

Global Multiple Endocrine Neoplasia Treatment Scope and Market Size
Multiple Endocrine Neoplasia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Endocrine Neoplasia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug Treatment
Surgery Treatment

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
West Coast Pharmaceuticals
Solvay
Unicure India
Sun Pharmaceuticals Industries
Macleods Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Endocrine Neoplasia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Surgery Treatment
1.3 Market by Application
1.3.1 Global Multiple Endocrine Neoplasia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multiple Endocrine Neoplasia Treatment Market Perspective (2016-2027)
2.2 Multiple Endocrine Neoplasia Treatment Growth Trends by Regions
2.2.1 Multiple Endocrine Neoplasia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiple Endocrine Neoplasia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Multiple Endocrine Neoplasia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Multiple Endocrine Neoplasia Treatment Industry Dynamic
2.3.1 Multiple Endocrine Neoplasia Treatment Market Trends
2.3.2 Multiple Endocrine Neoplasia Treatment Market Drivers
2.3.3 Multiple Endocrine Neoplasia Treatment Market Challenges
2.3.4 Multiple Endocrine Neoplasia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multiple Endocrine Neoplasia Treatment Players by Revenue
3.1.1 Global Top Multiple Endocrine Neoplasia Treatment Players by Revenue (2016-2021)
3.1.2 Global Multiple Endocrine Neoplasia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Multiple Endocrine Neoplasia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiple Endocrine Neoplasia Treatment Revenue
3.4 Global Multiple Endocrine Neoplasia Treatment Market Concentration Ratio
3.4.1 Global Multiple Endocrine Neoplasia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Endocrine Neoplasia Treatment Revenue in 2020
3.5 Multiple Endocrine Neoplasia Treatment Key Players Head office and Area Served
3.6 Key Players Multiple Endocrine Neoplasia Treatment Product Solution and Service
3.7 Date of Enter into Multiple Endocrine Neoplasia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Endocrine Neoplasia Treatment Breakdown Data by Type
4.1 Global Multiple Endocrine Neoplasia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Multiple Endocrine Neoplasia Treatment Forecasted Market Size by Type (2022-2027)

5 Multiple Endocrine Neoplasia Treatment Breakdown Data by Application
5.1 Global Multiple Endocrine Neoplasia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Multiple Endocrine Neoplasia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multiple Endocrine Neoplasia Treatment Market Size (2016-2027)
6.2 North America Multiple Endocrine Neoplasia Treatment Market Size by Type
6.2.1 North America Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021)
6.2.2 North America Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027)
6.2.3 North America Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2027)
6.3 North America Multiple Endocrine Neoplasia Treatment Market Size by Application
6.3.1 North America Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021)
6.3.2 North America Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027)
6.3.3 North America Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2027)
6.4 North America Multiple Endocrine Neoplasia Treatment Market Size by Country
6.4.1 North America Multiple Endocrine Neoplasia Treatment Market Size by Country (2016-2021)
6.4.2 North America Multiple Endocrine Neoplasia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Multiple Endocrine Neoplasia Treatment Market Size (2016-2027)
7.2 Europe Multiple Endocrine Neoplasia Treatment Market Size by Type
7.2.1 Europe Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2027)
7.3 Europe Multiple Endocrine Neoplasia Treatment Market Size by Application
7.3.1 Europe Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2027)
7.4 Europe Multiple Endocrine Neoplasia Treatment Market Size by Country
7.4.1 Europe Multiple Endocrine Neoplasia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Multiple Endocrine Neoplasia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Type
8.2.1 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Application
8.3.1 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Region
8.4.1 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multiple Endocrine Neoplasia Treatment Market Size (2016-2027)
9.2 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Type
9.2.1 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2027)
9.3 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Application
9.3.1 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2027)
9.4 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Country
9.4.1 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Multiple Endocrine Neoplasia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Type
10.2.1 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Application
10.3.1 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Country
10.4.1 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 West Coast Pharmaceuticals
11.1.1 West Coast Pharmaceuticals Company Details
11.1.2 West Coast Pharmaceuticals Business Overview
11.1.3 West Coast Pharmaceuticals Multiple Endocrine Neoplasia Treatment Introduction
11.1.4 West Coast Pharmaceuticals Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
11.1.5 West Coast Pharmaceuticals Recent Development
11.2 Solvay
11.2.1 Solvay Company Details
11.2.2 Solvay Business Overview
11.2.3 Solvay Multiple Endocrine Neoplasia Treatment Introduction
11.2.4 Solvay Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
11.2.5 Solvay Recent Development
11.3 Unicure India
11.3.1 Unicure India Company Details
11.3.2 Unicure India Business Overview
11.3.3 Unicure India Multiple Endocrine Neoplasia Treatment Introduction
11.3.4 Unicure India Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
11.3.5 Unicure India Recent Development
11.4 Sun Pharmaceuticals Industries
11.4.1 Sun Pharmaceuticals Industries Company Details
11.4.2 Sun Pharmaceuticals Industries Business Overview
11.4.3 Sun Pharmaceuticals Industries Multiple Endocrine Neoplasia Treatment Introduction
11.4.4 Sun Pharmaceuticals Industries Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
11.4.5 Sun Pharmaceuticals Industries Recent Development
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Details
11.5.2 Macleods Pharmaceuticals Business Overview
11.5.3 Macleods Pharmaceuticals Multiple Endocrine Neoplasia Treatment Introduction
11.5.4 Macleods Pharmaceuticals Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
11.5.5 Macleods Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multiple Endocrine Neoplasia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Surgery Treatment
Table 4. Global Multiple Endocrine Neoplasia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Multiple Endocrine Neoplasia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Multiple Endocrine Neoplasia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Multiple Endocrine Neoplasia Treatment Market Share by Regions (2016-2021)
Table 8. Global Multiple Endocrine Neoplasia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Multiple Endocrine Neoplasia Treatment Market Share by Regions (2022-2027)
Table 10. Multiple Endocrine Neoplasia Treatment Market Trends
Table 11. Multiple Endocrine Neoplasia Treatment Market Drivers
Table 12. Multiple Endocrine Neoplasia Treatment Market Challenges
Table 13. Multiple Endocrine Neoplasia Treatment Market Restraints
Table 14. Global Multiple Endocrine Neoplasia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Multiple Endocrine Neoplasia Treatment Market Share by Players (2016-2021)
Table 16. Global Top Multiple Endocrine Neoplasia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Endocrine Neoplasia Treatment as of 2020)
Table 17. Ranking of Global Top Multiple Endocrine Neoplasia Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Multiple Endocrine Neoplasia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Multiple Endocrine Neoplasia Treatment Product Solution and Service
Table 21. Date of Enter into Multiple Endocrine Neoplasia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Multiple Endocrine Neoplasia Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Multiple Endocrine Neoplasia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Multiple Endocrine Neoplasia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Multiple Endocrine Neoplasia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Multiple Endocrine Neoplasia Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Multiple Endocrine Neoplasia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Multiple Endocrine Neoplasia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Multiple Endocrine Neoplasia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Multiple Endocrine Neoplasia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Multiple Endocrine Neoplasia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Multiple Endocrine Neoplasia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Multiple Endocrine Neoplasia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Multiple Endocrine Neoplasia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. West Coast Pharmaceuticals Company Details
Table 62. West Coast Pharmaceuticals Business Overview
Table 63. West Coast Pharmaceuticals Multiple Endocrine Neoplasia Treatment Product
Table 64. West Coast Pharmaceuticals Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021) & (US$ Million)
Table 65. West Coast Pharmaceuticals Recent Development
Table 66. Solvay Company Details
Table 67. Solvay Business Overview
Table 68. Solvay Multiple Endocrine Neoplasia Treatment Product
Table 69. Solvay Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021) & (US$ Million)
Table 70. Solvay Recent Development
Table 71. Unicure India Company Details
Table 72. Unicure India Business Overview
Table 73. Unicure India Multiple Endocrine Neoplasia Treatment Product
Table 74. Unicure India Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021) & (US$ Million)
Table 75. Unicure India Recent Development
Table 76. Sun Pharmaceuticals Industries Company Details
Table 77. Sun Pharmaceuticals Industries Business Overview
Table 78. Sun Pharmaceuticals Industries Multiple Endocrine Neoplasia Treatment Product
Table 79. Sun Pharmaceuticals Industries Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021) & (US$ Million)
Table 80. Sun Pharmaceuticals Industries Recent Development
Table 81. Macleods Pharmaceuticals Company Details
Table 82. Macleods Pharmaceuticals Business Overview
Table 83. Macleods Pharmaceuticals Multiple Endocrine Neoplasia Treatment Product
Table 84. Macleods Pharmaceuticals Revenue in Multiple Endocrine Neoplasia Treatment Business (2016-2021) & (US$ Million)
Table 85. Macleods Pharmaceuticals Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Endocrine Neoplasia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drug Treatment Features
Figure 3. Surgery Treatment Features
Figure 4. Global Multiple Endocrine Neoplasia Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Multiple Endocrine Neoplasia Treatment Report Years Considered
Figure 9. Global Multiple Endocrine Neoplasia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Multiple Endocrine Neoplasia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Multiple Endocrine Neoplasia Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Multiple Endocrine Neoplasia Treatment Market Share by Regions (2022-2027)
Figure 13. Global Multiple Endocrine Neoplasia Treatment Market Share by Players in 2020
Figure 14. Global Top Multiple Endocrine Neoplasia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Endocrine Neoplasia Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Multiple Endocrine Neoplasia Treatment Revenue in 2020
Figure 16. Global Multiple Endocrine Neoplasia Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Multiple Endocrine Neoplasia Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Multiple Endocrine Neoplasia Treatment Market Share by Type (2016-2027)
Figure 20. North America Multiple Endocrine Neoplasia Treatment Market Share by Application (2016-2027)
Figure 21. North America Multiple Endocrine Neoplasia Treatment Market Share by Country (2016-2027)
Figure 22. United States Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Multiple Endocrine Neoplasia Treatment Market Share by Type (2016-2027)
Figure 26. Europe Multiple Endocrine Neoplasia Treatment Market Share by Application (2016-2027)
Figure 27. Europe Multiple Endocrine Neoplasia Treatment Market Share by Country (2016-2027)
Figure 28. Germany Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Multiple Endocrine Neoplasia Treatment Market Share by Region (2016-2027)
Figure 38. China Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Multiple Endocrine Neoplasia Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Multiple Endocrine Neoplasia Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Multiple Endocrine Neoplasia Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Multiple Endocrine Neoplasia Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Multiple Endocrine Neoplasia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. West Coast Pharmaceuticals Revenue Growth Rate in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
Figure 58. Solvay Revenue Growth Rate in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
Figure 59. Unicure India Revenue Growth Rate in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
Figure 60. Sun Pharmaceuticals Industries Revenue Growth Rate in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
Figure 61. Macleods Pharmaceuticals Revenue Growth Rate in Multiple Endocrine Neoplasia Treatment Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

以下、関連資料のご紹介

世界の希少内分泌疾患治療市場規模・現状・予測（2021年-2027年）

Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4938 2021年4月 97Pages
QYResearch社発行の本調査資料では、希少内分泌疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、有機化合物）、用途別市場規模（病院薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Primary Progressive Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4790 2021年4月 94Pages
QYResearch社発行の本調査資料では、一次進行性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、ラキニモドナトリウム、その他）、用途別市場規模（病院、診療所、...

世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年）

Global Multiple Myeloma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3954 2021年4月 91Pages
QYResearch社発行の本調査資料では、多発性骨髄腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別市場規模（病...

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3956 2021年4月 93Pages
QYResearch社発行の本調査資料では、多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫調節剤、免疫抑制剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の進行性再発性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Progressive Relapsing Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4818 2021年4月 99Pages
QYResearch社発行の本調査資料では、進行性再発性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別市場規模（診療所、病院、その他）、主要...

世界の内分泌ペプチド検査市場規模・現状・予測（2021年-2027年）

Global Endocrine Peptides Test Market Size, Status and Forecast 2021-2027
QYR2104Z2148 2021年4月 96Pages
QYResearch社発行の本調査資料では、内分泌ペプチド検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エストラジオール（E2）、デヒドロエピアンドロステロン硫酸塩（DHEAS）、ヒト絨毛性ゴナドトロピン（hCG）、プロゲステロン、黄体形...

世界の内分泌ペプチド検査市場規模・現状・予測（2021年-2027年）

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Sclerosis Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3955 2021年4月 90Pages
QYResearch社発行の本調査資料では、多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ベータインターフェロン、コルチコステロイド、モノクローナル抗体、抗腫瘍剤、その他）、用途別市場規模（病院薬局、小売薬局、eコマース）、主...

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年）

Global Multiple Myeloma Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3953 2021年4月 96Pages
QYResearch社発行の本調査資料では、多発性骨髄腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法・その他薬剤、放射線、幹細胞移植、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の希少内分泌疾患治療市場規模・現状・予測（2021年-2027年） The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive. The rare endocrine …
世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年） Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to acc…
世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…
世界の進行性再発性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Progressive Relapsing Multiple Sclerosis Treatment Market The global Progressive Relapsing Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standar…
世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…